Marshall Investment Management LLC Invests $1.38 Million in First Trust Nasdaq Pharmaceuticals ETF $FTXH

Marshall Investment Management LLC acquired a new position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 41,809 shares of the company’s stock, valued at approximately $1,377,000. Marshall Investment Management LLC owned 5.97% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. NBC Securities Inc. boosted its holdings in First Trust Nasdaq Pharmaceuticals ETF by 33.0% during the fourth quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock worth $44,000 after buying an additional 329 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF during the second quarter worth $57,000. Flagship Harbor Advisors LLC purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter worth $205,000. Stratos Wealth Partners LTD. purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF during the third quarter worth $230,000. Finally, Sound Income Strategies LLC purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter worth $287,000.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of NASDAQ FTXH opened at $34.87 on Tuesday. The company’s fifty day moving average price is $34.02 and its 200 day moving average price is $33.64. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $24.86 and a 1 year high of $35.61. The company has a market capitalization of $31.38 million, a PE ratio of 14.51 and a beta of 0.47.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Thursday, March 26th were issued a dividend of $0.0573 per share. This represents a $0.23 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Thursday, March 26th.

First Trust Nasdaq Pharmaceuticals ETF Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.